Clostridium perfringens is a gram-positive, anaerobic, spore-forming bacterium capable of producing four major toxins which cause disease symptoms and pathogenesis in humans and animals. C. perfringens strains carrying enterotoxins can cause food poisoning in humans and are associated with meat consumption. An endolysin, named LysCP28, is encoded by orf28 from C. perfringens bacteriophage BG3P. This protein has an N-terminal glycosyl–hydrolase domain (lysozyme) and a C-terminal SH3 domain. Purified LysCP28 (38.8 kDa) exhibited a broad spectrum of lytic activity against C. perfringens strains (77 of 96 or 80.21%), including A, B, C, and D types, isolated from different sources. Moreover, LysCP28 (10 μg/mL) showed high antimicrobial activity and was able to lyse 2 × 107 CFU/mL C. perfringens ATCC 13124 and C. perfringens J21 (animal origin) within 2 h. Necessary due to this pathogenic bacterium’s ability to form biofilms, LysCP28 (18.7 μg/mL) was successfully evaluated as an antibiofilm agent in both biofilm removal and formation inhibition. Finally, to confirm the efficacy of LysCP28 in a food matrix, duck meat was contaminated with C. perfringens and treated with endolysin (100 µg/mL and 50 µg/mL), which reduced viable bacteria by 3.2 and 3.08 units-log, respectively, in 48 h at 4 °C. Overall, the endolysin LysCP28 could potentially be used as a biopreservative to reduce C. perfringens contamination during food processing.
Clostridium perfringens is an important pathogen for both humans and animals, causing human foodborne disease and necrotic enteritis in poultry. In the present study, a C. perfringens-specific phage, vB_CpeS_BG3P (designated as BG3P hereafter), was isolated from chicken farm sewage. Both electron microscopy and phylogenetic analysis suggested that phage BG3P is a novel phage belonging to Siphoviridae family. Phage BG3P exhibited a broad host range against different C. perfringens isolates (90.63% of strains were infected). Sequencing of the complete genome revealed a linear double-stranded DNA (43,528 bp) with 28.65% GC content. After sequence analysis, 73 open reading frames (orfs) were predicted, of which only 13 were annotated with known functions. No tRNA and virulence encoding genes were detected. It should be noted that the protein of orf 15 has 97.92% homology to C. perfringens-specific chloramphenicol resistance protein, which has not been reported for any C. perfringens phage. Phylogenetic analysis of the ssDNA binding protein demonstrated that this phage is closely related to C. perfringens phages phiSM101 and phi3626. In considering future use as an antimicrobial agent, some biological characteristics were observed, such as a good pH (3–11) stability and moderate temperature tolerance (<60 °C). Moreover, bacteriophage BG3P showed a good antimicrobial effect against C. perfringens liquid cultures. Thus, phage treatment with MOI ≥ 100 completely inhibited bacterial growth compared to untreated cultures. Although phage BG3P shows good lytic efficiency and broad host range in vitro, future development and application may need to consider removal of the chloramphenicol-like resistance gene or exploring its lysin for future antibacterial applications.
Type I interferons (IFNs) are pleiotropic cytokines, primarily comprising IFN-α and IFN-β, and their effect in host defense against viral infection has been extensively studied and well-established. However, in bacterial infection, the role of type I IFNs is more complex, exhibiting multifaceted effects that depend on several factors, such as the pathogen species, the specific cell populations, and the routes of infection. In this review, we summarize research progress on host type I interferon responses triggered by specific bacteria and their immune regulation function in order to better understand the role of type I IFNs in bacterial infection and provide insights for adjuvant therapies tailored to treat specific bacterial infections.
Salmonellosis is a significant zoonotic and foodborne disease caused by Salmonella. As a primary host, poultry infections can result in decreased survival rates, diminished production performance and contamination of poultry products, thereby posing a se-rious threat to the sustainable development of poultry farming and human health. In this study, a total of 979 samples were collected from the laying hen production chain and 84 Salmonella strains were isolated with the isolation rate of 8.58% (84/979). Among these, 54 isolates (11.2%) were from commercial house samples, followed by 9 isolates (10.8%) from market samples, 10 isolates (5.88%) from hatchery samples, and 11 iso-lates (4.55%) from breeder house samples. Six different serotypes were identified, with Salmonella enteritidis being the predominant serotype (41.7%), followed by Salmonella typhimurium (22.6%) and Salmonella infantis (21.4%). The Salmonella enteritidis was distributed in various production stages in the laying hen production chain. Among the 16 antibiotics tested, 30 selected strains exhibited 100% resistance to nalidixic acid (NAL) and ciprofloxacin (CIP), attributed to mutations in the quinolone re-sistance-determining region (QRDR) of the gyrA gene. Following this, the resistance rates for ampicillin (AMP), amoxicillin-clavulanate (AMC), and streptomycin (STR) were 56.7%. Notably, isolates from commercial houses and markets displayed higher resistance rates, whereas those from breeder houses and hatcheries exhibited lower rates. Whole genome sequencing (WGS) phylogenetic analysis based on core genome single nucleotide polymorphism (cgSNP) revealed that Salmonella can spread across various stages of the laying hen production chain, posing a potential threat to human health. This study investigates the prevalence of Salmonella within the laying hen production chain, providing a scientific foundation for the effective prevention and control of Salmonella infection.
Salmonellosis is a significant zoonotic and foodborne disease caused by Salmonella. As a primary reservoir, poultry infections can result in decreased survival rates, diminished production performance and contamination of poultry products, thereby posing a serious threat to the sustainable development of poultry farming and human health. In this study, a total of 979 samples were collected from a laying hen production chain, and 84 Salmonella strains were isolated, with an isolation rate of 8.58% (84/979). Among these, 54 isolates (11.2%) were from commercial house samples, followed by nine isolates (10.8%) from market samples, 10 isolates (5.88%) from hatchery samples, and 11 isolates (4.55%) from breeder house samples. Six different serotypes were identified, with Salmonella enterica serovar Enteritidis (S. Enteritidis) being the predominant serotype (41.7%), followed by Salmonella enterica serovar Typhimurium (S. Typhimurium) (22.6%) and Salmonella enterica serovar Infantis (S. Infantis) (21.4%). The S. Enteritidis was distributed in various production stages in the laying hen production chain. Among the 16 antibiotics tested, 30 selected strains exhibited 100% resistance to nalidixic acid (NAL) and ciprofloxacin (CIP), attributed to mutations in the quinolone resistance-determining region (QRDR) of the gyrA gene. Following this, the resistance rates for ampicillin (AMP), amoxicillin–clavulanate (AMC), and streptomycin (STR) were 56.7%. Antimicrobial resistance genotypes were consistent with the drug resistance phenotype. Whole genome sequencing (WGS) phylogenetic analysis based on core genome single nucleotide polymorphism (cgSNP) revealed that Salmonella can spread across various stages of the laying hen production chain, posing a potential threat to human health. Furthermore, 165 virulence-associated genes were identified among the investigated isolates, indicating a highly conserved virulence repertoire. This study investigates the prevalence of Salmonella within a laying hen production chain, providing a scientific foundation for the effective prevention and control of Salmonella infection.